Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LIMNW

Liminatus Pharma, Inc.

CIK 0001971387 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.05
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals; Risks: Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$2.25M
P/E Ratio
-0.20
EPS
-0.43
Dividend Yield
Not covered
52W Position
6%
Beta
-0.30

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-16.99
P/S
Not covered
EV/Revenue
Not covered
ROE
8544.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.03$0.38

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$10.21M
Total Assets
$512.79K
Free Cash Flow
-$9.98M

Recent news